Peanuts vs. fatty liver: a 12-Week diet test begins

NCT ID NCT07646197

Recruiting now Disease control Sponsor: Henry Ford Health System Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Aug 07, 2026 · Updated 3 times

Summary

This study tests whether eating 50 grams of peanuts daily for 12 weeks can improve liver markers and gut health in adults with metabolic fatty liver disease (MASLD). 125 participants will be randomly assigned to either eat peanuts or stick to their regular diet. Researchers will measure changes in liver enzymes, cholesterol, blood sugar, and gut bacteria.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: peanuts
What this could lead to: If it works, this could point toward a simple dietary change to help manage fatty liver disease.
What could go wrong: This is a small, early-stage trial testing a food, not a drug. Results may be modest or not apply to everyone. Peanuts are high in calories, so weight gain is a possible risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fatty liver disease metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FATTY LIVER MASLD

Contacts and locations

Locations

Henry Ford Health System
RECRUITING

Detroit, Michigan, 48202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.